| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b64767ea9d24938cd379ea6c57d07743 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1767
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-56 |
| filingDate |
2003-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12b17a23f51d9baa9e0eac3055231bff |
| publicationDate |
2004-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004266672-A1 |
| titleOfInvention |
Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor |
| abstract |
The present invention provides methods of treating hemorrhagic fevers where selective inhibitors of fVIIa/TF are used as a treatment for hemorrhagic fevers and have therapeutic effects which include ameliorating and/or preventing coagulopathy and inflammatory responses. These inhibitors include certain proteins which are part of a family termed Nematode-Extracted Anticoagulant Proteins (“NAPs”). Other inhibitors include Tissue Factor Pathway Inhibitor (“TFPI”) and TFPI analogs. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007092607-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007092607-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022036366-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007076091-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007076091-A2 |
| priorityDate |
2003-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |